|

Autologous thyTreg Clinical Trials

1 actively recruiting trial

Also known as: thyTreg cells

Pipeline

Phase 1/2: 1

Top Sponsors

  • Rafael Correa-Rocha1

Indications

  • Heart Disease1
  • Heart Transplantation1

Other1 trial

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.